Privately-owned Servier of France has exercised an option to acquire equity in GeNeuro SA, a Swiss biotech that is poised to test a new antibody in patients with relapsing-remitting multiple sclerosis. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
